Gianluigi Savarese

Gianluigi Savarese

Associate Professor of Cardiology

FESC MD PhD

Karolinska Institute, Stockholm, SE

  • LinkedIn
  • Twitter
  • Radcliffe
  • OrcidID

Biography

Dr Gianluigi Savarese is currently an Associate Professor of Cardiology and Heart Failure Specialist at the Karolinska Institute in Stockholm, Sweden. 

Dr Savarese has served on the board for the European Society of Cardiology's Heart Failure Association since 2020, and has previously been a Nucleus member of a working group on Cardiovascular Pharmacotherapy for the ESC. He is a member of the Italian Society of Cardiology, and the Swedish Society of Cardiology. 

Dr Savarese attended the University of Naples Federico II University for his degree in Surgery and Medicine between 2004 - 2010. He then went on to stay at the same institution until 2016 as he completed his Specialism in Cardiovascular Diseases. He then continued his postgraduate studies at the University of Zurich between 2015-2017, where he continued his studies into Heart Failure. Finally, Dr Savarese completed his PhD at the Karolinska Institutet in 2018. 

Dr Savarese has published over 150 publications in peer-reviewed journals, focusing mainly on heart failure, epidemiology and cardiovascular pharmacotherapy. 

Dr Gianluigi Savarese is Section Editor of European Cardiology Review.

Read more

Media

Carolyn Lam, Carys Barton, Stephen J Greene, et al

Watch time: 1h 2m 19s (6 videos)

Gianluigi Savarese, Mark Petrie, Stephen J Greene, et al

Watch time: 57m 5s (4 videos)

Gianluigi Savarese, Orly Vardeny, Biykem Bozkurt, et al

Watch time: 28m 51s (2 videos)

Richard Schilling, KR Julian Chun, Isabel Deisenhofer, et al

Watch time: 15h 6m 7s (20 videos)
HFA 2020: Eligibility for sacubitril/valsartan in HF across the EF spectrum

Gianluigi Savarese,

Watch time: 7m 56s
image

Gianluigi Savarese,

Watch time: 2m 38s

Articles by Gianluigi Savarese, Associate Professor of Cardiology

Epidemiology, Clinical Characteristics and Cause-specific Outcomes in Heart Failure with Preserved Ejection Fraction

Chris J Kapelios, Bahira Shahim, Lars H Lund, et al

Published:

Citation: Cardiac Failure Review 2023;9:e14.

DOI:

https://doi.org/ 10.15420/cfr.2023.03
Global Public Health Burden of Heart Failure: An Updated Review

Bahira Shahim, Chris J Kapelios, Gianluigi Savarese, et al

Published:

Citation: Cardiac Failure Review 2023;9:e11.

DOI:

https://doi.org/10.15420/cfr.2023.05
New Trial Evidence on Heart Failure: Highlights from the European Society of Cardiology Congress 2021

Giulia Ferrannini, Gianluigi Savarese,

Published:

Citation: European Cardiology Review 2022;17:e12.

DOI:

https://doi.org/10.15420/ecr.2022.06
Evidence-based Therapy in Older Patients with Heart Failure with Reduced Ejection Fraction

Davide Stolfo, Gianfranco Sinagra, Gianluigi Savarese, et al

Published:

Citation: Cardiac Failure Review 2022;8:e16.

DOI:

https://doi.org/10.15420/cfr.2021.34
Behavioural Interventions to Reduce Cardiovascular Risk: Where Do We Stand?

Gianluigi Savarese,

Published:

Citation: European Cardiology Review 2019;14(3):139–40

DOI:

https://doi.org/10.15420/ecr.2019.14.3.GE3
Global Public Health Burden of Heart Failure

Gianluigi Savarese, Lars H Lund,

Citation: Cardiac Failure Review 2017;3(1):7–11.

DOI:

https://doi.org/10.15420/cfr.2016:25:2
Use of Renin–Angiotensin–Aldosterone System Inhibitors in Older Patients with Heart Failure and Reduced Ejection Fraction

Davide Stolfo, Gianluigi Savarese,

Published:

Citation: Cardiac Failure Review 2019;5(2):70–3.

DOI:

https://doi.org/10.15420/cfr.2019.6.2